New generation of biotherapies monitoring by mass spectrometry
mAbXmise is an innovation born from the combination of Promise Proteomics’ recognized expertise in mass spectrometry and its unique know-how in the production of internal standards for proteins assays. Today this innovative range is available in clinical practice to assist healthcare professionals in their decision making.
Three kits available: Oncology, Inflammation, Transplantation
Each kit includes:
96-well plate coated with stable labeled mAbs (internal standards)
Relevant buffers and solutions
This product is for research use only and is not intended for diagnostic or therapeutic use.
*Allumiqs distributes Promise Proteomics products exclusively in Canada and the United States. If you are not located in these regions, please visit the Promise Proteomics website for more information.